Tag: lebrikizumab
ADtouch Results: Hand and Foot Eczema Responds Well to Lebrikizumab – Medscape
eczemarelief
October 8, 2026
US FDA Approves Less Frequent Lebrikizumab Dosing in AD – The Dermatology Digest
eczemarelief
June 10, 2026
Significance of New Phase 3 Lebrikizumab Trial in Nummular Eczema, With Kilian Eyerich, MD, PhD – HCPLive
eczemarelief
May 23, 2026
Lebrikizumab plus TCS shows sustained disease control in refractory atopic dermatitis – Hospital Healthcare Europe
eczemarelief
December 10, 2025